Cargando…

The 2-Oxoglutarate Carrier Is S-Nitrosylated in the Spinal Cord of G93A Mutant hSOD1 Mice Resulting in Disruption of Mitochondrial Glutathione Transport

Mitochondrial oxidative stress and dysfunction are strongly implicated in the pathogenesis of amyotrophic lateral sclerosis (ALS). Glutathione (GSH) is an endogenous antioxidant that exists as distinct cytosolic and mitochondrial pools. The status of the mitochondrial GSH pool is reliant on transpor...

Descripción completa

Detalles Bibliográficos
Autores principales: Linseman, Daniel A., Winter, Aimee N., Wilkins, Heather M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855976/
https://www.ncbi.nlm.nih.gov/pubmed/36672568
http://dx.doi.org/10.3390/biomedicines11010061
_version_ 1784873507828531200
author Linseman, Daniel A.
Winter, Aimee N.
Wilkins, Heather M.
author_facet Linseman, Daniel A.
Winter, Aimee N.
Wilkins, Heather M.
author_sort Linseman, Daniel A.
collection PubMed
description Mitochondrial oxidative stress and dysfunction are strongly implicated in the pathogenesis of amyotrophic lateral sclerosis (ALS). Glutathione (GSH) is an endogenous antioxidant that exists as distinct cytosolic and mitochondrial pools. The status of the mitochondrial GSH pool is reliant on transport from the cytosol through the 2-oxoglutarate carrier (OGC), an inner membrane anion carrier. We have previously reported that the outer mitochondrial membrane protein, Bcl-2, directly binds GSH and is a key regulator of OGC-dependent mitochondrial GSH transport. Here, we show that G93A mutant SOD1 (Cu, Zn-superoxide dismutase) reduces the binding of GSH to Bcl-2 and disrupts mitochondrial GSH uptake in vitro. In the G93A mutant hSOD1 mouse model of ALS, mitochondrial GSH is significantly depleted in spinal cord of end-stage mice. Finally, we show that OGC is heavily S-nitrosylated in the spinal cord of end-stage mice and consequently, the GSH uptake capacity of spinal cord mitochondria isolated from these mutant mice is significantly diminished. Collectively, these findings suggest that spinal cord GSH depletion, particularly at the level of the mitochondria, plays a significant role in ALS pathogenesis induced by mutant SOD1. Furthermore, the depletion of mitochondrial GSH in the G93A mutant hSOD1 mouse model may be caused by the S-nitrosylation of OGC and the capacity of mutant SOD1 to disrupt the Bcl-2/GSH interaction, resulting in a disruption of mitochondrial GSH transport.
format Online
Article
Text
id pubmed-9855976
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98559762023-01-21 The 2-Oxoglutarate Carrier Is S-Nitrosylated in the Spinal Cord of G93A Mutant hSOD1 Mice Resulting in Disruption of Mitochondrial Glutathione Transport Linseman, Daniel A. Winter, Aimee N. Wilkins, Heather M. Biomedicines Article Mitochondrial oxidative stress and dysfunction are strongly implicated in the pathogenesis of amyotrophic lateral sclerosis (ALS). Glutathione (GSH) is an endogenous antioxidant that exists as distinct cytosolic and mitochondrial pools. The status of the mitochondrial GSH pool is reliant on transport from the cytosol through the 2-oxoglutarate carrier (OGC), an inner membrane anion carrier. We have previously reported that the outer mitochondrial membrane protein, Bcl-2, directly binds GSH and is a key regulator of OGC-dependent mitochondrial GSH transport. Here, we show that G93A mutant SOD1 (Cu, Zn-superoxide dismutase) reduces the binding of GSH to Bcl-2 and disrupts mitochondrial GSH uptake in vitro. In the G93A mutant hSOD1 mouse model of ALS, mitochondrial GSH is significantly depleted in spinal cord of end-stage mice. Finally, we show that OGC is heavily S-nitrosylated in the spinal cord of end-stage mice and consequently, the GSH uptake capacity of spinal cord mitochondria isolated from these mutant mice is significantly diminished. Collectively, these findings suggest that spinal cord GSH depletion, particularly at the level of the mitochondria, plays a significant role in ALS pathogenesis induced by mutant SOD1. Furthermore, the depletion of mitochondrial GSH in the G93A mutant hSOD1 mouse model may be caused by the S-nitrosylation of OGC and the capacity of mutant SOD1 to disrupt the Bcl-2/GSH interaction, resulting in a disruption of mitochondrial GSH transport. MDPI 2022-12-27 /pmc/articles/PMC9855976/ /pubmed/36672568 http://dx.doi.org/10.3390/biomedicines11010061 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Linseman, Daniel A.
Winter, Aimee N.
Wilkins, Heather M.
The 2-Oxoglutarate Carrier Is S-Nitrosylated in the Spinal Cord of G93A Mutant hSOD1 Mice Resulting in Disruption of Mitochondrial Glutathione Transport
title The 2-Oxoglutarate Carrier Is S-Nitrosylated in the Spinal Cord of G93A Mutant hSOD1 Mice Resulting in Disruption of Mitochondrial Glutathione Transport
title_full The 2-Oxoglutarate Carrier Is S-Nitrosylated in the Spinal Cord of G93A Mutant hSOD1 Mice Resulting in Disruption of Mitochondrial Glutathione Transport
title_fullStr The 2-Oxoglutarate Carrier Is S-Nitrosylated in the Spinal Cord of G93A Mutant hSOD1 Mice Resulting in Disruption of Mitochondrial Glutathione Transport
title_full_unstemmed The 2-Oxoglutarate Carrier Is S-Nitrosylated in the Spinal Cord of G93A Mutant hSOD1 Mice Resulting in Disruption of Mitochondrial Glutathione Transport
title_short The 2-Oxoglutarate Carrier Is S-Nitrosylated in the Spinal Cord of G93A Mutant hSOD1 Mice Resulting in Disruption of Mitochondrial Glutathione Transport
title_sort 2-oxoglutarate carrier is s-nitrosylated in the spinal cord of g93a mutant hsod1 mice resulting in disruption of mitochondrial glutathione transport
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855976/
https://www.ncbi.nlm.nih.gov/pubmed/36672568
http://dx.doi.org/10.3390/biomedicines11010061
work_keys_str_mv AT linsemandaniela the2oxoglutaratecarrierissnitrosylatedinthespinalcordofg93amutanthsod1miceresultingindisruptionofmitochondrialglutathionetransport
AT winteraimeen the2oxoglutaratecarrierissnitrosylatedinthespinalcordofg93amutanthsod1miceresultingindisruptionofmitochondrialglutathionetransport
AT wilkinsheatherm the2oxoglutaratecarrierissnitrosylatedinthespinalcordofg93amutanthsod1miceresultingindisruptionofmitochondrialglutathionetransport
AT linsemandaniela 2oxoglutaratecarrierissnitrosylatedinthespinalcordofg93amutanthsod1miceresultingindisruptionofmitochondrialglutathionetransport
AT winteraimeen 2oxoglutaratecarrierissnitrosylatedinthespinalcordofg93amutanthsod1miceresultingindisruptionofmitochondrialglutathionetransport
AT wilkinsheatherm 2oxoglutaratecarrierissnitrosylatedinthespinalcordofg93amutanthsod1miceresultingindisruptionofmitochondrialglutathionetransport